Allspring Global Investments Holdings, LLC Global Blood Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$32.4 - $68.18 $109,933 - $231,334
-3,393 Reduced 78.31%
940 $64,000
Q2 2022

Jul 25, 2022
SELL
$22.3 - $37.39 $855,673 - $1.43 Million
-38,371 Reduced 89.85%
4,333 $138,000
Q1 2022

May 02, 2022
BUY
$25.68 - $35.59 $138,081 - $191,367
5,377 Added 14.41%
42,704 $1.48 Million
Q4 2021

Jan 28, 2022
BUY
$24.9 - $40.26 $929,442 - $1.5 Million
37,327 New
37,327 $1.09 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email